Trends in incidence of total or type 2 diabetes: systematic review

Abstract

Objective To assess what proportions of studies reported increasing, stable, or declining trends in the incidence of diagnosed diabetes. Design Systematic review of studies reporting trends of diabetes incidence in adults from 1980 to 2017 according to PRISMA guidelines. Data sources Medline, Embase, CINAHL, and reference lists of relevant publications. Eligibility criteria Studies of open population based cohorts, diabetes registries, and administrative and health insurance databases on secular trends in the incidence of total diabetes or type 2 diabetes in adults were included. Poisson regression was used to model data by age group and year. Results Among the 22 833 screened abstracts, 47 studies were included, providing data on 121 separate sex specific or ethnicity specific populations; 42 (89%) of the included studies reported on diagnosed diabetes. In 1960-89, 36% (8/22) of the populations studied had increasing trends in incidence of diabetes, 55% (12/22) had stable trends, and 9% (2/22) had decreasing trends. In 1990-2005, diabetes incidence increased in 66% (33/50) of populations, was stable in 32% (16/50), and decreased in 2% (1/50). In 2006-14, increasing trends were reported in only 33% (11/33) of populations, whereas 30% (10/33) and 36% (12/33) had stable or declining incidence, respectively. Conclusions The incidence of clinically diagnosed diabetes has continued to rise in only a minority of populations studied since 2006, with over a third of populations having a fall in incidence in this time period. Preventive strategies could have contributed to the fall in diabetes incidence in recent years. Data are limited in low and middle income countries, where trends in diabetes incidence could be different. Systematic review registration Prospero CRD42018092287.

Diabetes and global ageing among 65–99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9th edition

“…The projections for 2030 (195 million) and 2045 (276 million) for people with diabetes in this age group appear dramatic but are likely to not only represent demographic-related sequelae, but also changes in incidence rates and survival, with the prevalence overall remaining just below the 20% level. It should be noted from a recent systematic review [7] that incidence rates of diabetes have actually declined in many high-income populations across all age groups since 2000 (perhaps because of the introduction of diabetes preventative programmes) although incidence data are lacking from the Pacific Islands, the Middle East, and South Asia, where diabetes prevalence has risen considerably. Other key observations from these new data demonstrate wide differences in the seven IDF Regions in terms of prevalence in those aged 65 years and older, for example, relatively low prevalences in AFR and SEA (8.4% and 13.6%, respectively) compared with 27% and 24.2% in NAC and Middle East and North Africa (MENA), respectively.…”

The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions

“…In addition to other factors, obesity is a major factor responsible for T2D worldwide. Its prevalence may further increase globally, with the highest projected prevalence rates in developing or low-income countries [63]. Therefore, deeper insights into obesity pathogenesis as a significant risk factor for T2D hold huge promise for obesity prevention and treatment [64,65].…”

Update on technologies, medicines and treatments

“…A new systematic review suggests that the incidence of type 2 diabetes, particularly in developed countries, is declining . The review included published data on the incidence of type 2 diabetes in more than 100 populations in mostly high‐income countries over five different time periods from 1970 to 2014.…”